The APRIL paradox in normal versus malignant B cell biology.

van Attekum, M H A; Kater, A P; Eldering, E

van Attekum, M H A; Kater, A P; Eldering, E.

Affiliation

van Attekum MH; Department of Hematology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam.
Kater AP; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam.
Eldering E; Department of Hematology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam.

Cell Death Dis ; 7(6): e2276, 2016 06 23.

Article in En | MEDLINE | ID: mdl-27336720

Subject(s)

B-Lymphocytes/metabolism; B-Lymphocytes/pathology; Tumor Necrosis Factor Ligand Superfamily Member 13/metabolism; Animals; CD40 Ligand/metabolism; Humans; Leukemia, Lymphocytic, Chronic, B-Cell/metabolism; Leukemia, Lymphocytic, Chronic, B-Cell/pathology; Mice, Knockout; Models, Biological

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B-Lymphocytes / Tumor Necrosis Factor Ligand Superfamily Member 13 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cell Death Dis Year: 2016 Document type: Article

Fulltext

XML

PubMed Links

Search on Google